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Background: Tissue regeneration in the lungs is gaining increasing interest as a potential influenza management
strategy. In this study, we explored the role of microRNAs, short non-coding RNAs involved in post-transcriptional
regulation, during pulmonary regeneration after influenza infection.
Results: We profiled miRNA and mRNA expression levels following lung injury and tissue regeneration using a
murine influenza pneumonia model. BALB/c mice were infected with a sub-lethal dose of influenza A/PR/8(H1N1)
virus, and their lungs were harvested at 7 and 15 days post-infection to evaluate the expression of ~300 miRNAs
along with ~36,000 genes using microarrays. A global network was constructed between differentially expressed
miRNAs and their potential target genes with particular focus on the pulmonary repair and regeneration processes
to elucidate the regulatory role of miRNAs in the lung repair pathways. The miRNA arrays revealed a global
down-regulation of miRNAs. TargetScan analyses also revealed specific miRNAs highly involved in targeting relevant
gene functions in repair such as miR-290 and miR-505 at 7 dpi; and let-7, miR-21 and miR-30 at 15 dpi.
Conclusion: The significantly differentially regulated miRNAs are implicated in the activation or suppression of cellular
proliferation and stem cell maintenance, which are required during the repair of the damaged lungs. These findings
provide opportunities in the development of novel repair strategies in influenza-induced pulmonary injury.
Keywords: Lung repair, Pulmonary regeneration, Influenza pneumonia, miRNAs, miRNome, TranscriptomeBackground
Vulnerability of lungs to influenza virus infection
Our lungs are constantly in contact with the external envir-
onment and exposed to airborne debris, pathogens and
chemicals, which can inflict damage acutely or chronically
[1]. Pathogens such as influenza virus can cause acute lung
injury (ALI) through acute viral pneumonia [2]. ALI
induced by influenza may also lead to complications that
severely impair pulmonary functions, and not only affect an
individual’s quality of life, but can also be life-threatening if* Correspondence: vincent_chow@nuhs.edu.sg
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unless otherwise stated.left untreated [2-5]. Furthermore, with the emergence of
pandemic H1N1-2009, avian H5N1 and H7N9 influenza
strains, and seasonal H1N1 and H3N2 strains, which cause
varying severity of ALI, there is a need for novel and timely
intervention strategies for post-influenza lung repair to
mitigate permanent tissue damage and its sequelae. Among
available options, promoting pulmonary tissue regeneration
represents an effective approach against influenza-induced
lung injury [6,7].Regenerative medicine as a novel influenza management
strategy
Influenza infection of the lungs constitutes an important
source of severe inflammatory damage to the lung architec-
ture via respiratory burst of the innate immune response
that cannot be generalized to other types of lung injury
[5,8]. The injury can give rise to complications and/or. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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susceptible groups such as the elderly and allergic individ-
uals with diminished repair functions to cope with these
infections [3,4]. Being a common respiratory pathogen, in-
fluenza has therefore been extensively investigated to eluci-
date its infection kinetics and pathogenicity by clinical
studies and animal models [9,10]. Hence, with better under-
standing of its kinetics, novel strategies can be formulated
based on the phases of the influenza infection process. The
repair stage of influenza pneumonia is gaining increasing
interest given that complications can be prevented if the
damaged lung architecture is restored appropriately. Stud-
ies on the recovery period of pulmonary influenza infection
have indicated changes in proliferative and differentiation
traits of lung epithelial cells [11,12], suggesting potential
regulation of these changes to facilitate the repair of dam-
aged lungs.
MicroRNAs as potential agents in post-influenza lung
repair strategies
MicroRNAs (miRNAs) are short RNA nucleotides in-
volved in post-transcriptional regulation, and are of
major interest in view of their ease of manipulation and
delivery into host cells due to their relatively small sizes
[13-15]. In addition, they regulate various disease pro-
cesses as well as normal physiologic functions, including
embryonic lung development [13-20]. The recent suc-
cess of miRNA-based drug discovery [21] further fuelled
our interest to screen for miRNAs that mediate repair of
influenza-afflicted lungs. We hypothesized that miRNAs
play major roles in priming pulmonary tissues for repair
and regeneration following influenza pneumonia, similar
to how miRNAs are intimately involved in embryonic
lung development [16,17].
This study aimed to investigate miRNAs that are dif-
ferentially regulated during the repair phases of influ-
enza using an established murine model of influenza
H1N1 pneumonia, drawing parallels to seasonal H1N1
infection that may culminate in pulmonary complica-
tions in susceptible individuals. Another objective was to
attain complete systems-level analysis to elucidate po-
tential miRNAs that are crucial for lung repair in vivo
[22]. These findings can improve our understanding of
influenza-induced lung repair responses, and also iden-
tify miRNA candidates for further validation as critical
players in pulmonary regeneration.
Results
Infected murine lungs exhibit similar degrees of damage,
while miRNA and mRNA microarray expression profiles
are largely homogenous at specific time-points
The lungs on 7 days post-infection (dpi) were scored
using a modified damage scoring system [23] to ascer-
tain that the mice suffered similar extents of damage,while lungs on 15 dpi were scored based on the area of
recovery. Lungs that displayed similar degrees of injury
within each individual time-point at 7 and 15 dpi were
subjected to miRNA and mRNA microarrays (Table 1).
Pearson correlation was computed between all samples
to compare the homogeneity of miRNA and mRNA ex-
pression within each animal group, which showed that
miRNA and mRNA expression profiles were generally
highly correlated. For subsequent analyses, only the probe-
set intensity data that were relatively homogenous between
replicates of the specific infected groups at 7 and 15 dpi
were included. Thus, consistent miRNA profiles from 3
mice at 7 dpi and 4 mice at 15 dpi, together with consistent
mRNA profiles from 4 mice each at 7 and 15 dpi were
analyzed (Additional file 1: Figure S1).Cell types, degree of cell proliferation and repair in the
lungs vastly differ between 7 and 15 dpi
Compared to uninfected control, histopathologic analyses
of infected lungs (Figure 1a) revealed more damaged areas,
and a greater number of infiltrating polymorphs at 7 dpi,
suggesting predominant innate immune responses against
the virus in the lungs. This finding is congruent with the
viral NS1 expression, which was still detected in lungs at 7
dpi (Figure 1b). Most areas of the lungs exhibited widening
interstitia and septae, with the presence of fibrin and red
blood cells. In contrast, at 15 dpi, while some features of
broncho-alveolar damage remained (i.e. apoptotic debris,
desquamation), viral expression was absent in the lungs.
Furthermore, the most striking change was the appearance
of new epithelial cells at 15 dpi. Also, the subjective in-
crease in all types of infiltrating cells on 15 dpi is likely to
account for the apparent increase in area of lung damage
compared with 7 dpi.
Immunohistochemistry (IHC) analyses with proliferat-
ing cell nuclear antigen (PCNA) and surfactant protein-
C (SP-C) staining were also conducted to ascertain the
degree of cellular proliferation, DNA synthesis and repair
in the lungs (specifically for alveolar type 2 or AT2 pneu-
mocytes). Minimal PCNA-positive cells were present in the
control mice at both days, while SP-C-positive AT2 pneu-
mocytes were evenly distributed across the lungs (Figure 1c).
Lungs of infected mice at 7 dpi displayed areas without SP-
C-positive cells likely attributed to virus-induced damage.
Increased PCNA-positive cells were observed in the in-
fected lungs. However, there was only a small percentage of
PCNA and SP-C double-positive cells at 7 dpi, which
was not significant compared to control uninfected lungs
(Figure 1d, e). On 15 dpi, multiple areas deprived of SP-C-
positive cells were likely attributed to pneumocytes dam-
aged by infection and innate immune responses. Relatively
more PCNA-positive cells as well as PCNA and SP-C
double-positive cells were observed in the lungs at 15 dpi,
Table 1 Damage scoring of infected murine lungs
Days & mice % lung affected Alveolar septae Hemorrhage Fibrin Infiltrate Score
7 dpi
Infected 1 30 3 1 1 3 3.9
Infected 2 40 3 1 1 3 5.2
Infected 3 30 3 1 1 3 3.9
Infected 4 50 3 1 1 3 6.5





Note: Histopathologic scoring to determine the homogeneity of lung damage at 7 and 15 dpi. The formula to derive the scores at 7 dpi is:% infected × [alveolar
hemorrhage + 2(alveolar inflitrates) + 3(fibrin) + alveolar septal congestion].
Figure 1 Histopathologic and IHC analyses of murine lungs. (a) The histopathologic images of infected lungs (H&E) portray considerably
greater extent of epithelial thickening and infiltration into the lungs at 7 dpi than 15 dpi (red circles). At 7 dpi, minimal repair processes were
observed other than wound healing (fibrin). In comparison, at 15 dpi, new epithelial and connective tissue filled the alveolar spaces (green
circles). (b) Expression of viral NS1 at 7 dpi indicated presence of virus, whereas complete viral clearance was evident at 15 dpi. (c) Dividing cells
(PCNA-positive) and AT2 pneumocytes (SP-C-positive) were stained by IHC to assess lung regeneration at both time-points. (d) Higher percentages of
PCNA-positive proliferating cells were noted in infected lungs at 7 dpi and especially at 15 dpi. (e) PCNA and SP-C double-positive dividing
cells were significantly higher in infected murine lungs at 15 dpi. N = 4 per group per time-point. Asterisks denote P < 0.05 compared to
uninfected control.
Tan et al. BMC Genomics 2014, 15:587 Page 3 of 13
http://www.biomedcentral.com/1471-2164/15/587
Tan et al. BMC Genomics 2014, 15:587 Page 4 of 13
http://www.biomedcentral.com/1471-2164/15/587indicating enhanced cell proliferation, DNA synthesis and
DNA repair of the pneumocytes.
General down-regulation of miRNAs and up-regulation of
genes at repair phases on both 7 and 15 dpi
The miRNA array data on both 7 and 15 dpi revealed a
global down-regulation of miRNAs (at false discovery
rate or FDR of 5%). On 7 dpi, 3 miRNAs were up-
regulated and 22 miRNAs were down-regulated out of
336 miRNAs analyzed. However, on 15 dpi, 12 miRNAs
were up-regulated and 114 down-regulated out of 314
miRNAs analyzed (Figure 2a). Table 2 outlines some of
the top significant miRNAs on both days. This landscape
suggests that miRNAs, being gene regulatory factors via
translational repression, were down-regulated to yield aug-
mented gene expression in response to H1N1 infection. In-
deed, the mRNA expression patterns were skewed towards
up-regulation in the infected groups, with 591 up-regulatedFigure 2 microRNA and gene microarray expression on 7 and 15 dpi.
fewer miRNAs and genes were differentially expressed at 7 dpi. However, m
was complete. In infected lung samples at both 7 and 15 dpi, the higher n
up-regulated genes. (b) Scatter plots showed negligible overlap between t
indicating that highly specific functions were operating during these two pgenes and 246 down-regulated genes at 7 dpi (out of 36,991
genes analyzed); and 1,768 up-regulated genes and 744
down-regulated genes at 15 dpi (out of 35,577 genes ana-
lyzed). In comparison, infected mice revealed ~5 times
more differentially expressed (DE) miRNAs (at least 1.3×
fold change) and ~3 times more DE genes (at least 1.5×
fold change) on 15 dpi compared to 7 dpi. This indicates
more significant alterations in expression at 15 dpi, pre-
sumably due to complete viral clearance. There was almost
no overlap between the DE miRNAs and genes between
the two time-points, implying that the biological processes
were largely distinct due to the different conditions of the
infected lungs at each time-point (Figure 2b).
Real-time RT-PCR data of representative significantly
DE miRNAs and genes indicated good consistency with
the microarray expression data (Figure 3). Thus, both
miR-335 and miR-582 were down-regulated at 7 dpi;
while miR-21 was up-regulated, miR-34b and miR-542(a) Representative heatmaps of microarrays revealed that relatively
ore alterations in expression occurred at 15 dpi, when viral clearance
umbers of down-regulated miRNAs coincided with the increase in
he differentially expressed miRNAs and genes at the two time-points,
hases of influenza pneumonia. N = 4 per group per time-point.
Table 2 Significantly differentially expressed (DE) murine
miRNAs at 7 and 15 dpi









































Table 2 Significantly differentially expressed (DE) murine




Note: The top 12 DE miRNAs on day 7, and the top 30 DE miRNAs on day 15
are listed. miRNAs with at least 1.3× fold change and P-value < 0.05 were
considered significantly DE.
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dpi, genes such as ANGPTL4 and PLAT were up-
regulated, while genes such as SOX4 and CTHRC1 were
down-regulated. At 15 dpi, genes such as EREG and
GDF6 were up-regulated, while genes such as ESM1 and
FGF1 were down-regulated. The directional trends of
changes in all the DE genes were consistent with the
array data, thus validating the accuracy of both miRNA
and gene microarrays.
Overall global gene networks by Ingenuity pathway
analysis (IPA)
Table 3 shows the top 5 IPA networks of the DE genes
for each time-point. At 7 dpi, functions and pathways
such as immune cell proliferation, inflammation, and
innate viral responses were significantly enriched (P <
0.05), while repair functions were relatively sparse. The
number of functions and pathways was much lower at 7
dpi likely due to viral presence and immediate innate
immune responses to combat the virus, thus masking
other functions. On the other hand, following viral clear-
ance by 15 dpi, innate immune responses were likely to
be largely replaced by more influenza-specific adaptive
responses that are more tightly controlled and regulated.
Thus, the pathway enrichment shifted from immune
responses to largely cellular responses of repair and prolif-
eration, such as DNA damage response, cellular prolifera-
tion, DNA replication and cell cycle activities (P < 0.05).
Repair pathway selection and gene ontology (GO)
analyses
To focus on miRNA regulatory activities in the relevant
biological functions, we applied the IPA function tree to
manually select genes that were annotated in repair,
development and regeneration functions. Thus, 227 and
876 genes were selected for further analyses for days 7
and 15 (out of a total of 837 and 2,512), respectively. In
this selection, the DE genes were mainly involved in cell
death, cell survival, cell cycle, cell proliferation, DNA
replication, and developmental functions.
The GO term analyses applied after the initial manual
selection revealed different processes occurring at each
time-point (Figure 4). At 7 dpi, only a relatively small
number of 53 GO terms were identified to be directly
involved in repair, mainly in tissue development, cell
Figure 3 Real-time RT-PCR verification of microarray data. Verification of microarray data by real-time RT-PCR (qPCR) assays revealed congruent results
for virtually all the 5 miRNAs and 20 genes tested for both time-points. These results confirmed the accuracy and validity of the microarrays performed.
N = 4 per group per time-point.
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repair and developmental functions during active viral
clearance. In contrast, 254 GO terms were found to be
associated directly with repair and development at 15
dpi. Many of them were predominantly involved mainly
in cell cycle, cell death, tissue development and growth
factors, which corroborates the repair and replacement
of damaged lung tissue occurring at 15 dpi.
TargetScan reveals the close relationship between
miRNAs and selected repair-related genes
To evaluate the extent to which miRNAs were involved
with gene regulation in repair and regeneration, TargetScan
analyses of the DE miRNAs targeting the selected genes
related to repair and regeneration were applied after
the GO analyses. Thus, the DE genes were furthernarrowed down to 61 up- and 43 down-regulated genes
at 7 dpi, targeted by the corresponding 2 up- and 10
down-regulated miRNAs. At 15 dpi, there were 556 up-
and 193 down-regulated repair-related genes targeted by
the corresponding 12 up- and 91 down-regulated miR-
NAs. When the DE miRNA and repair-associated genes
were paired by TargetScan, we thus observed 12 miRNAs
at 7 dpi and 103 miRNAs at 15 dpi highly involved in tar-
geting repair-associated genes that were differentially reg-
ulated at both time-points. Figure 5 shows the major
targets of the altered miRNAs grouped into their respective
GO terms. The high frequency of repair GO terms target-
ing genes in cell cycle, differentiation, wound healing, tissue
development and angiogenesis, implied that the repair and
regeneration of lung tissues following influenza pneumonia
were tightly modulated by miRNAs.
Table 3 Ingenuity pathway analysis of enriched pathways during different repair phases
Day 7 networks Score
Hematological system development and function, Tissue morphology, Cellular development 52
Antimicrobial response, Inflammatory response, Infectious Disease 40
Cell-to-cell signaling and interaction, Cellular growth and proliferation, Hematological system development and function 37
Cardiovascular system development and function, Cell morphology, Hematological system development and function 31
Cell-to-cell signaling and interaction, Cellular function and maintenance, Hematological system development and function 31
Day 15 networks Score
Nucleic acid metabolism, Small molecule biochemistry, Cellular development 42
Cell-to-cell signaling and interaction, Cell signaling, Nucleic acid metabolism 40
DNA replication, recombination, and repair, Cell cycle, Cellular assembly and organization 36
Cell death and survival, Cell-to cell signaling and interaction, Hematological system development and function 35
Cellular compromise, DNA replication, recombination and repair, Energy production 35
Note: IPA analysis based on gene function enrichment. Enrichment score is a modified P-value and indicates the likelihood of the Focus Genes in a network being
found together due to random chance. A score of 2 denotes that there is a 1-in-100 chance that the Focus Genes are together in a network due to random
chance. Therefore, scores of 2 or higher have at least 99% confidence of not being generated by random chance alone.
Tan et al. BMC Genomics 2014, 15:587 Page 7 of 13
http://www.biomedcentral.com/1471-2164/15/587Selection of candidates having high association with lung
repair functions
To screen for the final list of potential candidate miRNA
regulators of repair and regeneration, we applied other
criteria (Figure 6a). The rationale of this additional filter
is that miRNAs changes are usually subtle, and therefore
selecting those significantly DE miRNAs with the highest
or lowest raw abundance in the control samples would
likely culminate in a larger magnitude of change and ef-
fect in response to infection. These additional criteria
narrowed the selection down to 3 miRNAs at 7 dpi
(miR-290, miR-1940, miR-505) which were marked to be
crucial in the early repair phase. At 15 dpi, 17 miRNAs
(let-7b,c, miR-10a, miR-21, miR-25, miR-26a, miR-29c,
miR-30a,b,c,d, miR-99a, miR-103, miR-151, miR-195,
and miR-200b,c) were identified to be important in the
late repair phase. Most of these miRNAs were also foundFigure 4 Summary of lung repair-associated gene functions targeted
genes based on their summarized functions (GO) showed that more repair
proportion of cell cycle, cell death, and growth factor-related genes, accomto target genes in lung developmental GO terms, render-
ing them the most likely regulators of the transcriptome
in influenza-induced pulmonary repair (Figure 6b).
Possible functions of high-scoring miRNAs involved in
targeting the lung repair pathway
Of the 20 shortlisted miRNAs, their putative functions
associated with lung repair were inferred through litera-
ture searches. (Additional file 2: Table S4) indicates that
the DE miRNAs on days 7 and 15 largely differ in their
functions. The miRNAs at 7 dpi were engaged in
endothelial and fibroblast proliferation (wound healing),
whereas miRNAs at 15 dpi were more broadly involved
in cell proliferation, apoptosis, tumor suppression and
DNA repair, consistent with the functional annotation.
The full list of targets of these shortlisted miRNAs is
provided in Additional file 3: Table S1.by their associated miRNAs at 7 and 15 dpi. Lung repair-related
functions occurred on day 15. There was a marked increase in the
panied by a decrease of differentiation and wound healing genes.
Figure 5 Further refinement of miRNA selection to identify physiologically important miRNAs during repair. Integrated miRNA and gene
(GO term) networks of selected miRNA candidates. (a) At 7 dpi, the network was relatively moderate, with a focus on targeting tissue development. (b)
At 15 dpi, an extensive network was involved in pulmonary repair and regeneration mainly by targeting cell cycle functions. It is likely that most miRNAs
were down-regulated possibly to facilitate developmental gene expression.
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miRNAs are believed to play crucial roles during the
repair of the lungs following injury. We therefore identi-
fied miRNAs that are differentially regulated in a time-
dependent manner during the early and later recovery
phases of the lungs using a murine influenza infection
model. The recovery time-points were selected based
on previously documented kinetics of lung-repairing
cell types initially present on day 7 (early phase) and
that peak on day 15 (late phase) [10,12]. Our in vivo
investigation unveiled potential candidate miRNAs
strongly associated with pulmonary repair and regener-
ation after acute inflammatory lung injury due to influ-
enza pneumonia.
Marked expression of repair, proliferation and
differentiation genes after viral clearance at 15 dpi
At 7 dpi, we observed highly specific differential expres-
sion of mainly inflammatory and viral innate immune
response-related genes in the lungs. This likely reflects the
specific commitment of damaged lungs to combat viral
infection rather than for repair functions. In addition, the
respiratory burst of innate immune responses also causesoxidative stress and DNA damage, culminating in
greater genetic instability and apoptosis which ham-
per cellular proliferation for replacing damaged cells
[24-26]. However, day 15 corresponds to the later
phase of recovery, characterized by viral clearance e.g.
by lymphocytes in the lungs to execute more specific
adaptive responses. The emergence of new immature
epithelial cells as indicated by histologic analyses as
well as increased PCNA-positive cells also suggest
re-epithelialization of lung tissues following viral clear-
ance. This was evident from the patches of PCNA-
positive cells within areas devoid of SP-C-positive
cells, which may reflect epithelial progenitor cells or
lung stem cells prior to differentiating into new pneu-
mocytes to replace the damaged ones. Regeneration
was also illustrated by the significantly increased
double-positive cells lining the edges of these SP-C-
deprived areas. Therefore, more efficient repair pro-
cesses would be expected at 15 dpi, with less oxidative
stress when the respiratory burst subsided in the lungs.
Alveolar epithelial cells could thus be replaced more
readily since repair would less likely be compromised
by DNA damage and mutation [26].
Figure 6 Targets of the top 20 miRNA candidates in lung repair. (a) Selection criteria to filter physiologically important miRNAs associated
with lung repair for further characterization. (b) Most of the GO term targets of the top 20 miRNAs were involved in cell cycle and gene
expression. The predominant down-regulation of most of the top 20 miRNAs likely permits enhanced expression of their respective gene targets
during pulmonary repair. miR-99a was not included since it targets only a small number of mRNAs.
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repair and development
The number of DE miRNAs was directly proportional to
the number of DE genes involved in repair and develop-
ment. Most DE miRNAs directly target repair-associated
genes, especially at 15 dpi when extensive repair oc-
curred. The close association between miRNAs and lung
development has been documented [13,19,27-29]. The
differentially regulated miRNAs were unique with almost
no overlap between the two time-points, indicating that
miRNA expression changed transiently according to the
temporal gene expression requirements in the lungs.
The top 20 miRNA candidates were identified, together
with their roles and targets during the lung repair phases
following influenza infection. Some of these miRNAs are
highly involved in development, regeneration, and cancer
progression due to their apparent roles in proliferation and
tumor suppression. This underscores that tissue repair en-
tails essentially tightly controlled proliferation as opposedto uncontrolled proliferation in cancer which involves simi-
lar factors [19].
We therefore postulate that the increase of certain stem
cell-associated miRNAs (e.g. miR-290) promotes the stem-
ness of cells during influenza-induced lung repair [30-32].
The let-7 miRNAs are implicated in developmental func-
tions and cellular proliferation, and also regulate and inhibit
proliferation in a cancer context. Therefore, their transi-
ently diminished expression during repair may facilitate the
proliferation of new tissues [33-35]. The miR-200 family is
often enriched in epithelial tissues, and their decreased
expression is linked to epithelial-mesenchymal transi-
tion and cell stemness. Hence, their reduced expression
may suggest enhanced plasticity of epithelial cells in
repairing lungs to replace damaged areas [36]. Lowered
miR-200 expression may also augment endothelial de-
velopment to repair the lung vasculature [37]. Interest-
ingly, Li et al [38] found that miR-200a is differentially
expressed in influenza virus infection, and that miRNA
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miR-21 targets proliferation-suppressing factors, and its
elevated expression during repair coincides with increased
proliferation in repairing lungs [39]. Notably, increased
miR-21 may cause detrimental effects due to their targets
in the TGF-β pathway, suggesting that miR-21 knockdown
may prevent lung complications such as fibrosis [40]. On
the other hand, some other miRNAs are possibly involved
in the regulation and surveillance of repair to prevent un-
controlled cell proliferation. Thus, members of the miR-
30 family were significantly down-regulated so that ex-
pression of its main target p53 could be suitably elevated
to counteract the higher proliferation in recovering lung
tissues, which are more prone to DNA damage and muta-
tion in the presence of increased DNA synthesis [41].
Hence, miR-30 appears to act as a tumor suppressor, with
its subdued expression facilitating proliferation, but con-
currently activating the negative feedback loop of p53,
thus showcasing the intricate roles that miRNAs play in
pulmonary damage and repair [42].
The functions of the physiologically important miRNAs
during tissue repair may reflect an intermediate state
between organismal development and cancer progres-
sion. Transient and controlled changes in expression of
proliferation activators and inhibitors may lead to a
state akin to development in contrast to cancer pro-
gression, as highlighted by the vastly different DE
miRNA profiles between days 7 and 15.
miRNAs and their potential applications in lung tissue
damage and repair
This study revealed that the regulation of miRNAs was
unique during different phases of repair after influenza
infection. The regulatory roles of these miRNAs in tissue
repair can be tested for their veracity in improving lung
repair and the overall outcome of influenza pneumonia.
For example, due to the nature of miRNA targeting,
some of these miRNAs (such as miR-21 and let-7) may
even serve dual roles of limiting damage and accelerat-
ing repair as they possess anti-inflammatory properties
besides regulating pulmonary repair activities, i.e. they
may minimize damage from inflammation secondary to
infection [43,44]. Therefore, future studies are warranted
to further characterize the potential miRNA candidates
in vitro and in vivo, in order to determine their detailed
roles in ALI and repair following influenza pneumonia.
Conclusion
We anticipate that many of the biological processes ob-
served during influenza lung damage and repair may
also be relevant to other types of viral infection and lung
injury, and will therefore contribute to our basic under-
standing of tissue repair of damaged lungs. Ultimately,
this integrative systems biology approach highlights thesignificant roles of the miRNAs in acute inflammatory
lung injury and regeneration, and revealed certain
miRNAs that may be instrumental in the repair and re-
construction of the lung architecture post-infection.
Methods
Virus strain and infection of animals
All animal experiments with 6–8 week old female
BALB/c mice were approved by the Institutional Animal
Care and Use Committee (IACUC), National University
of Singapore (protocol 050/11), and fulfilled all listed cri-
teria in the ARRIVE guidelines (Additional file 4). Mice
were housed in ABSL-2 facilities in ventilated cages ac-
cording to IACUC guidelines. Animals were divided into
4 groups each consisting of 4 mice, i.e. control unin-
fected and infected groups at 7 and 15 dpi. The two
time-points were chosen based on the kinetics of influ-
enza infection, i.e. when repair of primary viral damage
commences and certain repair cell types initially appear
at 7 dpi, whereas repair of inflammatory damage begins
after viral clearance and when repair cell types peak at
15 dpi [10,12]. Mice were anesthetized with a mixture of
7.5 mg/ml ketamine and 0.1 mg/ml medetomidine, and
infected intra-tracheally with a sub-lethal dose of 23
plaque-forming units of influenza A/Puerto Rico/8/1934
(H1N1) or PR8 virus (in 50 μl volume) to ensure that all
mice recovered from the infection. Control mice were
given phosphate-buffered saline (PBS) intra-tracheally.
Mice were monitored daily for weight loss from infec-
tion and weight gain from recovery. Upon reaching the
stipulated time-point, mice were euthanized in a CO2
chamber, and the lungs harvested for histology and RNA
extraction.
Murine lung tissue processing and extraction of miRNAs
and mRNAs
Approximately 10% of each lobe of lung was snap-frozen
at -80°C to preserve RNAs. The lungs were then homoge-
nized in Trizol solution (Qiagen, Hilden, Germany) using a
gentleMACS tissue dissociator (Miltenyi Biotec, Bergisch
Gladbach, Germany), and total RNA was immediately ex-
tracted using the miRNeasy miRNA extraction kit (Qiagen).
The isolated total RNA samples containing miRNAs were
then subjected to miRNA and gene microarray analyses.
Histolopathologic analyses
The remaining 90% of each lung was fixed in 4% forma-
lin, dehydrated in ascending ethanol concentrations,
embedded in paraffin, sectioned into 4-μm slices, and
stained with hematoxylin and eosin (H&E). Ideally, the
lungs could be inflated prior to fixation. Notwithstanding
this, highly satisfactory assessment of the infected areas was
achieved by an experienced pulmonary pathologist to
include: inflammatory cell infiltration (polymorphs and
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edema (for tissue damage); and new progenitor cells
and re-epithelization (for tissue repair and replace-
ment). This evaluation was then correlated with the
molecular analyses. Scoring of damage to ascertain the
homogeneity of the infection was also conducted for
mouse lungs at 7 dpi based on a modified scoring sys-
tem, i.e.% infected × [alveolar hemorrhage + 2(alveolar
inflitrates) + 3(fibrin) + alveolar septal congestion] [23].
The scoring was carried out based on the worst-
affected area of the lungs, which then yielded the per-
centage of the lung area showing similar scores. Since
mice at 15 dpi were recovering and could not be scored
with the same system, the percentage of lung area
affected by the infection was obtained instead to ascer-
tain the homogeneity of damage.
Immunohistochemistry (IHC)
Paraffin-embedded blocks of lung tissues were also sec-
tioned into 5-μm slices for IHC analyses. The slides were
dewaxed with two washes of xylene, rehydrated with two
washes of 100% ethanol, and one wash each of 90%, 70%
and 50% ethanol, followed by two washes of deionized
water. Slides were then subjected to antigen retrieval in
boiling sodium citrate buffer with Tween 20. Slides were
further permeated with 0.025% of Triton X-100 for
10 min, before being blocked with 3% BSA for 2 h.
Primary antibodies for PCNA (SC-9857, Santa Cruz
Biotechnology, Dallas, TX) and SP-C (SC-13979, Santa
Cruz Biotechnology) at 100× dilution in 3% BSA were
used for co-staining dividing and repairing cells and
AT2 pneumocytes, respectively. Following overnight in-
cubation at 4°C in the dark, the slides were washed with
Tris-buffered saline thrice for 5 min each, and stained
with secondary antibody containing Alexa Fluor 488 for
PCNA and Alexa Fluor 568 for SP-C (Molecular Probes,
Grand Island, NY) at room temperature for 1 h in the
dark. Slides were then washed and mounted in colloidal
gold Antifade mounting medium with DAPI (Molecular
Probes). Slides were then concurrently scanned with the
high-resolution MIRAX MIDI system equipped with
fluorescence illumination (Carl Zeiss, Jena, Germany) for
the complete lung image to quantify dividing AT2 pneu-
mocytes. Stained sections were also visualized with a
FX-1000 confocal microscope at higher magnification.
Image analyses for quantification of dividing AT2
pneumocytes in the lungs
An automated computer algorithm was developed to
count the number of total cells, PCNA-positive cells,
and PCNA-positive AT2 pneumocytes. Nuclei were seg-
mented by converting the DAPI fluorescence channel
into black-and-white using manual thresholding of DAPI
intensities, and removing areas less than 3 pixels in size.The number of nuclei was counted as the number of
total cells. The PCNA fluorescence channel was next
converted to black-and-white using manual thresholding
of PCNA intensities. PCNA-positive nuclei were identi-
fied by selecting co-localized areas of nuclei and PCNA
channel, and performing dilating-hole filling-eroding
using “disk” operator with 3 pixels in size. The number
of PCNA-positive nuclei was counted as the number of
PCNA-positive cells. Finally, the SP-C fluorescence
channel was converted into black-and-white using man-
ual thresholding of SP-C intensities, and areas less than
2 pixels in size were ignored. The surrounding areas of
PCNA-positive nuclei (1 pixel in radius) were then
checked for SP-C signal in the SP-C channel. The num-
ber of PCNA-positive nuclei with surrounding SP-C sig-
nal was counted as the number of PCNA-positive AT2
cells. All image processing and computation algorithms
were implemented using MATLAB with image process-
ing toolbox (MathWorks, Natick, MA). The MATLAB
codes are available upon request.
miRNA and gene microarray analyses
Extracted total RNAs containing miRNAs were sub-
jected to quality control using a bio-analyzer to ensure
proper RNA quality before the microarray experiments.
Total RNA samples from 4 mice per group were then hy-
bridized individually onto the respective microarray plat-
forms (Agilent, Santa Clara, CA). The miRNA microarray
was a Mouse miRNA, 8 × 60 K format platform (AMADID
38112), while the gene microarray was a SurePrint G3
Mouse GE, 8 × 60 K, 1 color format platform (AMADID
028005). A total of 32 arrays (i.e. 16 miRNA arrays and 16
mRNA arrays) were hybridized to total RNA samples ex-
tracted from the lungs of 4 infected mice and 4 control
mice for each 7 and 15 dpi. The expression values of the
array probes were calculated following the manufacturer’s
standard array protocol. Only probes above the expression
threshold of 20 (raw signal intensity) were used to derive
expression values.
The expression data for the filtered probes of both
miRNA (1,179 probes) and gene (55,681 probes) micro-
arrays were normalized using quantile normalization,
and were subjected to DE analyses using QPROT soft-
ware (an extension of the QSPEC software for generic
expression data with missing values). DE genes were
identified using the Z-statistics threshold that controls
the FDR at 5% [45]. The DE miRNAs and genes were
further analyzed below to shortlist candidates associated
with active roles in pulmonary repair and regeneration.
Real-time RT-PCR validation of miRNA and gene
expression
A total of 5 miRNAs and 20 genes that were significantly
regulated at both 7 and 15 dpi were selected for real-time
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the microarray data. A stem-loop primer miRNA Universal
TaqMan RT-PCR system (Applied Biosystems, Foster City,
CA) was utilized to validate miRNAs, and normalized
using murine SNORD68 small nucleolar RNA [46,47]. The
miRNA stem-loop primers, specific forward primers and
universal reverse primer are listed in Additional file 5: Table
S2. Real-time RT-PCR assays to validate 20 genes were per-
formed using reverse transcription with random hexamers
(Promega, Madison, WI), the SYBR Green Master mix
and LightCycler real-time PCR system (Roche, Penzberg,
Germany), normalized against the RPL13a gene (Additional
file 6: Table S3).Developmental pathway and TargetScan analyses
The DE genes identified above were filtered for repair-
associated genes by the following criteria. Functional se-
lection for repair association was performed manually
using the function tree of the IPA software (Qiagen),
where genes under developmental and repair functional
groups were identified. These genes were then filtered
again with the hypergeometric test and FDR control (the
Benjamini-Hochberg procedure), and GO analysis [48].
A concurrent miRNA TargetScan analysis at a PCT score
of 0.5 was performed using the GeneSpring GX software
(Agilent), and only miRNAs that target the filtered genes
from the previous steps were selected. The selected
genes (grouped as GO terms at P < 0.05) and miRNAs
were then visualized in a network with Cytoscape soft-
ware (v3.0.1).Further refinement of miRNA candidate selection
To further narrow down the selected miRNA candidates,
an additional filter system of miRNA raw abundance in
control samples was taken into account. Therefore, a
final set of miRNAs was selected based on their statis-
tical significance, targeting related GO term members of
gene analysis, highest or lowest raw abundance in con-
trol samples where the fold changes were deemed more
significant. The selected miRNAs were then classified
based on their expression changes and their implicated
functions, and also whether they target genes directly as-
sociated with lung development and regeneration.Statistical analyses
FDR calculation and GO enrichment analyses of the
array dataset were performed using R statistics software
for selection of significant DE miRNAs and genes. Student’s
one sample t-test was performed on real-time RT-PCR veri-
fication and dividing AT2 pneumocyte quantification data
with GraphPad and SPSS software. Results were repre-
sented as mean ± standard deviation (SD).Additional files
Additional file 1: Figure S1. Scatter plot showing between-sample
correlation of probe-set intensity in infected groups (miRNA and mRNA
expression at both 7 and 15 dpi).
Additional file 2: Table S4. miRNAs of higher significance based on
selection criteria. Implicated functions of 20 shortlisted DE miRNAs.
Additional file 3: Table S1. Significantly DE mRNAs targeted by the
top 20 shortlisted miRNAs (with directional changes).
Additional file 4: ARRIVE guideline checklist.
Additional file 5: Table S2. Sequences (5′-3′) of stem-loop RT primers,
real-time specific forward primers and real-time universal reverse primer
for miRNA RT-PCR validation.
Additional file 6: Table S3. Sequences (5′–3′) of forward and reverse
primers for real-time quantitative RT-PCR of selected genes.
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